Listen for Gliptin Patients Complaining of Severe Joint Pain

A new FDA warning will spur questions about whether "gliptin" diabetes meds (Januvia, Onglyza, Kombiglyze XR, etc) cause joint pain.

This is stemming from reports of patients on gliptins who developed severe, and sometimes disabling, pain in their joints.

The theory is that gliptins MIGHT lead to an enhanced inflammatory response in the body...causing pain and possibly swelling.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote